Home / Import refusals / AEK-9338523-3/10003/1

FDA Import Refusal AEK-9338523-3/10003/1 — ASTRAZENCA PHARMA INDIA PVT LTD

ASTRAZENCA PHARMA INDIA PVT LTD — FEI 3017190135

The FDA refused shipment AEK-9338523-3/10003/1 from ASTRAZENCA PHARMA INDIA PVT LTD (India) on June 29, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.

Refusal Details

Date
June 29, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75

Other import refusals

  • AEK-8322401-2/11/1 (Wed Mar 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-1006551-2/11/1 (Wed Apr 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources